The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 25, 2022
Filed:
Nov. 30, 2017
Applicant:
Mereo Biopharma 5, Inc., Redwood City, CA (US);
Inventors:
Jakob Dupont, Hillsborough, CA (US);
Hema Parmar, San Mateo, CA (US);
Assignee:
MEREO BIOPHARMA 5, INC., Redwood City, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/24 (2006.01); A61P 35/00 (2006.01); C07K 5/10 (2006.01); C07K 5/12 (2006.01); C07K 14/47 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/24 (2013.01); A61P 35/00 (2018.01); C07K 5/10 (2013.01); C07K 5/12 (2013.01); C07K 14/47 (2013.01); C07K 16/2803 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); C07K 2317/76 (2013.01); Y02A 50/30 (2018.01);
Abstract
Methods for enhancing the immune response and/or treatment of diseases such as cancer comprising an agent that specifically binds TIGIT are disclosed. The TIGIT-binding agents may include polypeptides, antibodies, and/or bispecific agents.